Tag: Phase 3 trial

Rigel Pharmaceuticals Signs Global Licensing Deal for VEPPANUโ„ข Breast Cancer Treatment

Rigel Pharmaceuticals has entered an exclusive global licensing agreement with Arvinas and…

ME Desk

GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent

GE HealthCare has dosed the first patient in its Phase 2/3 LUMINA…

ME Desk

Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…

ME Desk